The global NSAID API market size was valued at US$ million in 2023. With growing demand in downstream market, the NSAID API is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global NSAID API market. NSAID API are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of NSAID API. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the NSAID API market.
Active pharmaceutical ingredients (APIs) are bulk drug products that are used as raw materials for formulations. Nonsteroidal anti-inflammatory drugs (NSAIDs) are a drug class that groups together drugs that provide analgesic (pain-killing) and antipyretic (fever-reducing) effects, and, in higher doses, anti-inflammatory effects.
North America dominated the global NSAID API market due to high demand for APIs in drug formulations and research and development programs in this region. The region is expected to continue its dominance in the coming years owing to increasing preference for generic medicines as a result of high healthcare costs in the U.S. Among other regions, Asia-Pacific is the next largest market for APIs. This region has become the most attractive market due to clustering of a large number of generic medicine manufacturers.
Key Features:
The report on NSAID API market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the NSAID API market. It may include historical data, market segmentation by Type (e.g., Paracetamol, Ibuprofen), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the NSAID API market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the NSAID API market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the NSAID API industry. This include advancements in NSAID API technology, NSAID API new entrants, NSAID API new investment, and other innovations that are shaping the future of NSAID API.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the NSAID API market. It includes factors influencing customer ' purchasing decisions, preferences for NSAID API product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the NSAID API market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting NSAID API market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the NSAID API market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the NSAID API industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the NSAID API market.
Market Segmentation:
NSAID API market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
Paracetamol
Ibuprofen
Aspirin
Naproxen
Others
Segmentation by application
Captive Manufacturing
Contract Manufacturing
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Novartis
Pfizer
Boehringer Ingelheim
Teva Pharmaceutical
BASF
Hospira
Lonza Group
Mylan
Aurobindo Pharma
Cambrex
Dr. Reddy's Laboratories
Actavis
Wuxi Apptec
Zhejiang NHU
Key Questions Addressed in this Report
What is the 10-year outlook for the global NSAID API market?
What factors are driving NSAID API market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do NSAID API market opportunities vary by end market size?
How does NSAID API break out type, application?
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global NSAID API Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for NSAID API by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for NSAID API by Country/Region, 2019, 2023 & 2030
2.2 NSAID API Segment by Type
2.2.1 Paracetamol
2.2.2 Ibuprofen
2.2.3 Aspirin
2.2.4 Naproxen
2.2.5 Others
2.3 NSAID API Sales by Type
2.3.1 Global NSAID API Sales Market Share by Type (2019-2024)
2.3.2 Global NSAID API Revenue and Market Share by Type (2019-2024)
2.3.3 Global NSAID API Sale Price by Type (2019-2024)
2.4 NSAID API Segment by Application
2.4.1 Captive Manufacturing
2.4.2 Contract Manufacturing
2.5 NSAID API Sales by Application
2.5.1 Global NSAID API Sale Market Share by Application (2019-2024)
2.5.2 Global NSAID API Revenue and Market Share by Application (2019-2024)
2.5.3 Global NSAID API Sale Price by Application (2019-2024)
3 Global NSAID API by Company
3.1 Global NSAID API Breakdown Data by Company
3.1.1 Global NSAID API Annual Sales by Company (2019-2024)
3.1.2 Global NSAID API Sales Market Share by Company (2019-2024)
3.2 Global NSAID API Annual Revenue by Company (2019-2024)
3.2.1 Global NSAID API Revenue by Company (2019-2024)
3.2.2 Global NSAID API Revenue Market Share by Company (2019-2024)
3.3 Global NSAID API Sale Price by Company
3.4 Key Manufacturers NSAID API Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers NSAID API Product Location Distribution
3.4.2 Players NSAID API Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for NSAID API by Geographic Region
4.1 World Historic NSAID API Market Size by Geographic Region (2019-2024)
4.1.1 Global NSAID API Annual Sales by Geographic Region (2019-2024)
4.1.2 Global NSAID API Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic NSAID API Market Size by Country/Region (2019-2024)
4.2.1 Global NSAID API Annual Sales by Country/Region (2019-2024)
4.2.2 Global NSAID API Annual Revenue by Country/Region (2019-2024)
4.3 Americas NSAID API Sales Growth
4.4 APAC NSAID API Sales Growth
4.5 Europe NSAID API Sales Growth
4.6 Middle East & Africa NSAID API Sales Growth
5 Americas
5.1 Americas NSAID API Sales by Country
5.1.1 Americas NSAID API Sales by Country (2019-2024)
5.1.2 Americas NSAID API Revenue by Country (2019-2024)
5.2 Americas NSAID API Sales by Type
5.3 Americas NSAID API Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC NSAID API Sales by Region
6.1.1 APAC NSAID API Sales by Region (2019-2024)
6.1.2 APAC NSAID API Revenue by Region (2019-2024)
6.2 APAC NSAID API Sales by Type
6.3 APAC NSAID API Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe NSAID API by Country
7.1.1 Europe NSAID API Sales by Country (2019-2024)
7.1.2 Europe NSAID API Revenue by Country (2019-2024)
7.2 Europe NSAID API Sales by Type
7.3 Europe NSAID API Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa NSAID API by Country
8.1.1 Middle East & Africa NSAID API Sales by Country (2019-2024)
8.1.2 Middle East & Africa NSAID API Revenue by Country (2019-2024)
8.2 Middle East & Africa NSAID API Sales by Type
8.3 Middle East & Africa NSAID API Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of NSAID API
10.3 Manufacturing Process Analysis of NSAID API
10.4 Industry Chain Structure of NSAID API
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 NSAID API Distributors
11.3 NSAID API Customer
12 World Forecast Review for NSAID API by Geographic Region
12.1 Global NSAID API Market Size Forecast by Region
12.1.1 Global NSAID API Forecast by Region (2025-2030)
12.1.2 Global NSAID API Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global NSAID API Forecast by Type
12.7 Global NSAID API Forecast by Application
13 Key Players Analysis
13.1 Novartis
13.1.1 Novartis Company Information
13.1.2 Novartis NSAID API Product Portfolios and Specifications
13.1.3 Novartis NSAID API Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Novartis Main Business Overview
13.1.5 Novartis Latest Developments
13.2 Pfizer
13.2.1 Pfizer Company Information
13.2.2 Pfizer NSAID API Product Portfolios and Specifications
13.2.3 Pfizer NSAID API Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Pfizer Main Business Overview
13.2.5 Pfizer Latest Developments
13.3 Boehringer Ingelheim
13.3.1 Boehringer Ingelheim Company Information
13.3.2 Boehringer Ingelheim NSAID API Product Portfolios and Specifications
13.3.3 Boehringer Ingelheim NSAID API Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Boehringer Ingelheim Main Business Overview
13.3.5 Boehringer Ingelheim Latest Developments
13.4 Teva Pharmaceutical
13.4.1 Teva Pharmaceutical Company Information
13.4.2 Teva Pharmaceutical NSAID API Product Portfolios and Specifications
13.4.3 Teva Pharmaceutical NSAID API Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Teva Pharmaceutical Main Business Overview
13.4.5 Teva Pharmaceutical Latest Developments
13.5 BASF
13.5.1 BASF Company Information
13.5.2 BASF NSAID API Product Portfolios and Specifications
13.5.3 BASF NSAID API Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 BASF Main Business Overview
13.5.5 BASF Latest Developments
13.6 Hospira
13.6.1 Hospira Company Information
13.6.2 Hospira NSAID API Product Portfolios and Specifications
13.6.3 Hospira NSAID API Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Hospira Main Business Overview
13.6.5 Hospira Latest Developments
13.7 Lonza Group
13.7.1 Lonza Group Company Information
13.7.2 Lonza Group NSAID API Product Portfolios and Specifications
13.7.3 Lonza Group NSAID API Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Lonza Group Main Business Overview
13.7.5 Lonza Group Latest Developments
13.8 Mylan
13.8.1 Mylan Company Information
13.8.2 Mylan NSAID API Product Portfolios and Specifications
13.8.3 Mylan NSAID API Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Mylan Main Business Overview
13.8.5 Mylan Latest Developments
13.9 Aurobindo Pharma
13.9.1 Aurobindo Pharma Company Information
13.9.2 Aurobindo Pharma NSAID API Product Portfolios and Specifications
13.9.3 Aurobindo Pharma NSAID API Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Aurobindo Pharma Main Business Overview
13.9.5 Aurobindo Pharma Latest Developments
13.10 Cambrex
13.10.1 Cambrex Company Information
13.10.2 Cambrex NSAID API Product Portfolios and Specifications
13.10.3 Cambrex NSAID API Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 Cambrex Main Business Overview
13.10.5 Cambrex Latest Developments
13.11 Dr. Reddy's Laboratories
13.11.1 Dr. Reddy's Laboratories Company Information
13.11.2 Dr. Reddy's Laboratories NSAID API Product Portfolios and Specifications
13.11.3 Dr. Reddy's Laboratories NSAID API Sales, Revenue, Price and Gross Margin (2019-2024)
13.11.4 Dr. Reddy's Laboratories Main Business Overview
13.11.5 Dr. Reddy's Laboratories Latest Developments
13.12 Actavis
13.12.1 Actavis Company Information
13.12.2 Actavis NSAID API Product Portfolios and Specifications
13.12.3 Actavis NSAID API Sales, Revenue, Price and Gross Margin (2019-2024)
13.12.4 Actavis Main Business Overview
13.12.5 Actavis Latest Developments
13.13 Wuxi Apptec
13.13.1 Wuxi Apptec Company Information
13.13.2 Wuxi Apptec NSAID API Product Portfolios and Specifications
13.13.3 Wuxi Apptec NSAID API Sales, Revenue, Price and Gross Margin (2019-2024)
13.13.4 Wuxi Apptec Main Business Overview
13.13.5 Wuxi Apptec Latest Developments
13.14 Zhejiang NHU
13.14.1 Zhejiang NHU Company Information
13.14.2 Zhejiang NHU NSAID API Product Portfolios and Specifications
13.14.3 Zhejiang NHU NSAID API Sales, Revenue, Price and Gross Margin (2019-2024)
13.14.4 Zhejiang NHU Main Business Overview
13.14.5 Zhejiang NHU Latest Developments
14 Research Findings and Conclusion
听
听
*If Applicable.
